Other Clinical Trial - Holo CTO Proctoring Study

Status Completed

Clinical Trial Summary

Assess Microsoft HoloLens as an interactive communication device in remote proctoring, and enhancement of teamwork in complex CTO procedures

Clinical Trial Description

Proctoring in medicine is related to better outcomes. Specifically, in CTO PCI systematic proctoring has demonstrated improved success rates, and an increased ability to treat lesions that are more complex. Most likely, proctoring together with operator volume is one of the foundations to the introduction and execution of CTO procedures. Proctoring traditionally involves an expert operator (proctor), visiting the institution, performing the procedure together with the local operator. This involves increased cost, and current travel restrictions makes traditional one-on-one proctoring challenging. This study aims to evaluate the Microsoft HoloLens as a potential platform in proctoring and effective real time communication between PCI operators located at different geographical locations. The proctor and the local operator interact using a head mounted mixed reality (MR) display, enabling the proctor to see the same image as the operator, from any distanced location. ;

Study Design

Related Conditions & MeSH terms

Chronic Total Occlusion of Coronary Artery
Percutaneous Coronary Intervention

Clinical Trial Details

NCT number	NCT05377866
Study type	Observational
Source	Sorlandet Hospital HF
Contact
Status	Completed
Phase
Start date	November 4, 2021
Completion date	January 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03959072` - Cardiac Cath Lab Staff Radiation Exposure
Not yet recruiting	`NCT05669222` - The FAVOR V AMI Trial	N/A
Recruiting	`NCT04566497` - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.	N/A
Recruiting	`NCT05240781` - Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk	N/A
Recruiting	`NCT03378934` - Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention	Phase 4
Not yet recruiting	`NCT06025071` - Residual Inflammatory Risk-Guided colcHicine in Elderly Trial	Phase 4
Withdrawn	`NCT04043091` - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction	N/A
Completed	`NCT02837744` - Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
Completed	`NCT03085823` - The All-comers Sirolimus-coated Balloon European Registry
Completed	`NCT02044146` - A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk	Phase 2/Phase 3
Completed	`NCT03131271` - Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention	N/A
Completed	`NCT01156571` - A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)	Phase 3
Completed	`NCT01135667` - Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI	Phase 4
Unknown status	`NCT00751491` - Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)	Phase 3
Completed	`NCT00725868` - Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention	N/A
Completed	`NCT03708588` - Chewed Versus Integral Pill of Ticagrelor	Phase 4
Completed	`NCT04163393` - R-One Efficiency For PCI Evolution With Robotic Assistance	N/A
Recruiting	`NCT05554588` - Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI	N/A
Recruiting	`NCT06080919` - Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).	N/A
Recruiting	`NCT05353140` - LAAO Versus NOAC in Patients With AF and PCI	N/A